Your browser doesn't support javascript.
loading
Targeting CXCL1 chemokine signaling for treating cisplatin ototoxicity.
Al Aameri, Raheem F H; Alanisi, Entkhab M A; Oluwatosin, Adu; Al Sallami, Dheyaa; Sheth, Sandeep; Alberts, Ian; Patel, Shree; Rybak, Leonard P; Ramkumar, Vickram.
Afiliação
  • Al Aameri RFH; Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL, United States.
  • Alanisi EMA; Department of Pharmaceutical Sciences, Larkin University College of Pharmacy, Miami, FL, United States.
  • Oluwatosin A; Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL, United States.
  • Al Sallami D; Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL, United States.
  • Sheth S; Department of Pharmaceutical Sciences, Larkin University College of Pharmacy, Miami, FL, United States.
  • Alberts I; Medical Microbiology, Immunology and Cell Biology (MMICB), Southern Illinois University School of Medicine, Springfield, IL, United States.
  • Patel S; Medical Microbiology, Immunology and Cell Biology (MMICB), Southern Illinois University School of Medicine, Springfield, IL, United States.
  • Rybak LP; Department of Surgery, Southern Illinois University School of Medicine, Springfield, IL, United States.
  • Ramkumar V; Department of Pharmacology, Southern Illinois University School of Medicine, Springfield, IL, United States.
Front Immunol ; 14: 1125948, 2023.
Article em En | MEDLINE | ID: mdl-37063917

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ototoxicidade / Perda Auditiva Tipo de estudo: Etiology_studies Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ototoxicidade / Perda Auditiva Tipo de estudo: Etiology_studies Limite: Animals Idioma: En Revista: Front Immunol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos País de publicação: Suíça